Hardware Podcasts

HIBT Lab! Mark Cuban Cost Plus Drug Company: Mark Cuban

How I Built This · 16 Jun 2022 · 34m

What this episode covers

Serial entrepreneur Mark Cuban discusses his newest venture, the Mark Cuban Cost Plus Drug Company (MCCPDC), which he co-founded with radiologist Alex Oshmiansky to disrupt the pharmaceutical industry by offering generic drugs at transparent, low costs. Cuban explains how he educated himself on the complex drug pricing ecosystem, identifying Pharmacy Benefit Managers (PBMs) and vertically integrated insurance companies as the primary drivers of inflated prices rather than manufacturing costs. He details the company's business model as a public benefit corporation that charges a flat 15% markup plus handling and shipping fees, bypassing traditional insurance rebates to undercut standard co-pays. Cuban also touches on his interest in NFTs, his strategy for staying grounded through social media feedback, and his belief that wealthy individuals have a responsibility to fund solutions for systemic problems like high drug prices.

Most relevant to

early-stage companies

Topics

Mentioned

Companies
Mark Cuban Cost Plus Drug Company, TruePill, Dallas Mavericks, Walmart, National Institute of Health
Also
Alex Oshmiansky, Ryan Klein, Shark Tank, Rareable, Mentable, Ethereum, Martin Shkreli, Dara Prim, Pharmacy Benefit Managers

Related episodes from other shows

Other shows on the same ground, closest first.

  • Let's Combinate · 42m

    036 - "Those Moments Keep You Grounded" with Yousef Arman

    Yousef Arman, founder of The Vial Store, explains how his family's pharmacy background and the challenges of independent pharmacy economics led to his venture. He details the operational complexities of running pharmacies, including state regulations, insurance reimbursements, and the impact of Pharmacy Benefit Managers (PBMs). Arman describes The Vial Store's evolution from a failed physical inventory model to a successful online drop-shipping and direct sourcing business, highlighting key decisions on logistics, pricing, and supplier relationships.

    Starting a product companyPricing, margins & unit economics
    7 chapters

  • Let's Combinate · 33m

    075 - Shortages, Pricing, Mastering New Skills, and Building Deep Understanding with Ben Locwin

    Ben Locwin, Executive SME at Black Diamond Networks, discusses the economic drivers of FDA drug shortages, arguing that pricing and demand elasticity are more critical than manufacturing failures. He highlights how high-cost therapies like cell treatments face different shortage dynamics than low-margin generics, citing specific examples like Ozempic and Adderall. Locwin also outlines his methodology for mastering new regulatory and scientific subjects, emphasizing deep research and the importance of identifying 'strings' that haven't been pulled yet in industry analysis.

    Policy, trade & tariffsPricing, margins & unit economics
    9 chapters

  • Let's Combinate · 32m

    046 - "Inflation Reduction Act" with Sarfaraz Niazi

    Dr. Sarfaraz Niazi, founder of Pharmaceutical Scientist Inc. and Adello Biologics, explains the provisions of the Inflation Reduction Act, specifically the $2,000 out-of-pocket cap for Medicare Part D and the $35 monthly cap on insulin. He clarifies that the bill allows CMS to negotiate prices for 10 drugs rather than imposing price controls, arguing this will not harm pharmaceutical profits or innovation. Niazi also discusses the distinction between Medicare and private insurance reimbursement models and advocates for extending insulin caps to private markets.

    Policy, trade & tariffs
    6 chapters

  • Let's Combinate · 42m

    109 - Protecting Patients at All Costs, Being a CQO in Big Pharma, Supply Chain Security and Generic Drugs with Martin Van Trieste

    Martin Van Trieste, former CQO at Amgen and CEO of Civica Rx, discusses the critical importance of supply chain security and quality leadership in pharmaceutical manufacturing. He details the creation of RX-360 following the heparin contamination crisis and explains how Civica Rx addresses drug shortages by restructuring business models to make essential generic drugs economically viable for manufacturers. Van Trieste argues that systemic design, rather than just compliance, is key to preventing human error and ensuring patient safety across the industry.

    Quality & yieldSourcing & supply chain
    9 chapters

  • People of Packaging · 1h 10m

    350 - Beyond the Dieline - Dr Juan from PNuff Crunch joins Tom Seymour

    Dr. Juan Salinas, founder of Pnuff Crunch, discusses his transition from food science roles at Nabisco, Cadbury, Kraft, and Nestle to launching his own functional snack brand. He details the operational challenges of scaling production, specifically the costly mistake of over-purchasing long-run packaging film rolls and the strategic pivot to digital printing and smart plate design to manage inventory. Salinas also recounts his viral Shark Tank appearance, where Mark Cuban’s intervention saved the pitch, leading to Cuban’s investment, and explains how Pnuff Crunch’s high-protein, high-fiber formulation targets modern dietary trends including GLP-1 companion foods.

    Crowdfunding & preordersPricing, margins & unit economics
    7 chapters

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by How I Built This. The episode itself belongs to its publisher.